Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
31/07/2009	14h00	PR Newswire (US)	Insmed to Host Second Quarter 2009 Conference Call	NASDAQ:INSM	Insmed Inc
27/07/2009	14h20	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:INSM	Insmed Inc
27/07/2009	14h00	PR Newswire (US)	Insmed Provides Update on Supply of IPLEX(TM)	NASDAQ:INSM
14/07/2009	15h00	Marketwired	BenchmarkJournal.com Free Analyst Review for LULU, GMCR, INSM, FTWR, AVNR and CLNE	NASDAQ:INSM	Insmed Inc
30/06/2009	14h00	PR Newswire (US)	Insmed Announces Addition to the Russell 3000(R) Index	NASDAQ:INSM
29/06/2009	15h13	Marketwired	TheFortuneFinancial.com Free Market Research on VZ, BZ, CAR, HEV, CM and INSM	NASDAQ:INSM	Insmed Inc
26/06/2009	15h05	PR Newswire (US)	Beacon Equity Features Market Research on: J.C. Penny, Zimmer, Dr Pepper, NCI Building, Lear and Insmed	NASDAQ:INSM	Insmed Inc
25/06/2009	14h00	PR Newswire (US)	Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy	NASDAQ:INSM
15/06/2009	22h45	PR Newswire (US)	Insmed CEO Resigns Due to Health Concerns	NASDAQ:INSM
09/06/2009	13h40	Marketwired	AnalystChoice.com Brings You the Best Complimentary Research Report on LPNT, LNCR, VITA and INSM	NASDAQ:INSM	Insmed Inc
22/05/2009	22h18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
15/05/2009	15h49	Marketwired	TheFortuneFinancial.com Initializes Free Analyst Research on NKTR, DPTR, NCMI and INSM	NASDAQ:INSM	Insmed Inc
14/05/2009	15h17	PR Newswire (US)	Stock Alerts on Industry Leaders: INTC, INSM, GD, ZGEN, YRCW, LEA; Issued by Beacon Equity	NASDAQ:INSM	Insmed Inc
13/05/2009	22h28	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:INSM	Insmed Inc
13/05/2009	13h00	PR Newswire (US)	Insmed Announces First Quarter 2009 Financial Results	NASDAQ:INSM
05/05/2009	14h00	PR Newswire (US)	Insmed Regains NASDAQ Compliance	NASDAQ:INSM	Insmed Inc
23/04/2009	14h00	PR Newswire (US)	Insmed to Host First Quarter 2009 Conference Call	NASDAQ:INSM
21/04/2009	15h34	Marketwired	MaybachFinancial.com Posts Free Analyst Report on INSM, SEPR, UAUA and OFIX	NASDAQ:INSM	Insmed Inc
16/04/2009	22h34	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:INSM	Insmed Inc
10/04/2009	22h32	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSM	Insmed Inc
31/03/2009	23h11	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:INSM	Insmed Inc
31/03/2009	23h06	PR Newswire (US)	Insmed Completes Sale of Follow-On Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million	NASDAQ:INSM
30/03/2009	23h30	PR Newswire (US)	Insmed Announces Agreement With IDIS to Manage Expanded Access Programs for IPLEX(TM)	NASDAQ:INSM
25/03/2009	13h00	PR Newswire (US)	Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule	NASDAQ:INSM
11/03/2009	12h00	PR Newswire (US)	Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results	NASDAQ:INSM
10/03/2009	18h39	PR Newswire (US)	Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND	NASDAQ:INSM
26/02/2009	14h00	PR Newswire (US)	Insmed to Host Fourth Quarter and Full-Year 2008 Conference Call	NASDAQ:INSM
12/02/2009	13h00	PR Newswire (US)	Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million	NASDAQ:INSM	Insmed Inc
12/02/2009	13h00	Business Wire	Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed	NASDAQ:INSM	Insmed Inc
10/02/2009	22h54	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NASDAQ:INSM	Insmed Inc